MX1

Vincerx Pharma Presents Preclinical Data on Novel Small Molecule Drug Conjugates at the American Association for Cancer Research (AACR) Annual Meeting 2023

Retrieved on: 
Monday, April 17, 2023
SMDC, TNBC, Rat, AACR, Therapy, CPT, Neoplasm, PALO, Cancer, American Association for Cancer Research, MX1, IC50, Plasma, HT29, Patient, NE, Half-life, AUC, Mouse, Poster, Spacecraft, NCI, Tumor microenvironment, Safety, Vaccine, Pharmaceutical industry, Palladium

PALO ALTO, Calif., April 17, 2023 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today presented a poster of preclinical data on novel integrin αvβ3-targeted small molecule drug conjugates (SMDCs) at the American Association for Cancer Research (AACR) Annual Meeting.

Key Points: 
  • PALO ALTO, Calif., April 17, 2023 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today presented a poster of preclinical data on novel integrin αvβ3-targeted small molecule drug conjugates (SMDCs) at the American Association for Cancer Research (AACR) Annual Meeting.
  • Vincerx’s next-generation modular bioconjugation platform is designed to effectively target tumors with different modalities, including SMDCs and antibody-drug conjugates (ADCs).
  • “The preclinical data presented at AACR demonstrate our ability to synthesize and characterize novel SMDCs,” said Ahmed Hamdy M.D., Chief Executive Officer of Vincerx.
  • Furthermore, these encouraging results demonstrate the extensive scientific expertise of the Vincerx team and our commitment to discovering and developing paradigm-shifting conjugates for patients with cancer.

Arelion Launches Two Routes Connecting US to Mexico

Retrieved on: 
Tuesday, November 15, 2022
Cloud, OTT, Ecosystem, IBM Cloud, ICT, Equinix, Carrier, Internet, City, Pop, Google Cloud Connect, Ethernet, Amazon Web Services, IP, Telia Carrier, MX1, KIO, Google Cloud, DWDM, QRO, Microsoft, Ottawa, Azure, IPX, Solution, Internet service provider, Wavelength, Oracle

STOCKHOLM, Nov. 15, 2022 /PRNewswire/ -- Mexico Connect 2022 -- Arelion (formerly Telia Carrier) today announced two new fully diverse routes from the US into Monterrey, continuing its expansion into Mexico's markets. These high-capacity routes will provide seamless, reliable connectivity that improves upon legacy cables in the region. As an early leader in open optical networking, Arelion's routes leverage the latest open optical line systems and support multi-vendor 400G wave capability, including Bright ZR+ disaggregated optics, offering resilient local connectivity and flexible high-speed access to content, application and cloud providers in the US.

Key Points: 
  • STOCKHOLM, Nov. 15, 2022 /PRNewswire/ -- Mexico Connect 2022 -- Arelion (formerly Telia Carrier) today announced two new fully diverse routes from the US into Monterrey, continuing its expansion into Mexico's markets.
  • These high-capacity routes will provide seamless, reliable connectivity that improves upon legacy cables in the region.
  • Arelion delivers an end-to-end seamless customer experience from sales, to delivery, to ongoing operation and support for customers seeking solutions between the US and Mexico.
  • "Legacy routes in the region cannot handle Mexico's increased demand for cost-effective, multi-Terabit bandwidth and diverse routing options," said Luis Velasquez, Mexico Business Manager, Arelion.

Inspur Information Showcases Leading Advances in AI Servers and Research at CVPR22

Retrieved on: 
Monday, June 20, 2022
Research, Apps, Applications, Technology, Software, Audio, Video, Networks, Hardware, Data Management, Science, Artificial Intelligence, Solution, CVPR, Gen4 Energy, Environment, Technology, Perception, NVIDIA, AMD, Conference on Computer Vision and Pattern Recognition, Student, Research, Engineering, Information, Computer vision, MX1, Software, Cloud computing, Deep learning, Machine learning, AI, Transformers

Inspur Information, a leading provider of AI solutions, will attend the Computer Vision and Pattern Recognition (CVPR) conference showcasing its advanced AI capabilities and end-to-end solutions, from servers to software.

Key Points: 
  • Inspur Information, a leading provider of AI solutions, will attend the Computer Vision and Pattern Recognition (CVPR) conference showcasing its advanced AI capabilities and end-to-end solutions, from servers to software.
  • The expo features the largest gathering of industry leaders in the field of computer vision, machine learning, and AI.
  • On display at the expo are Inspur Informations high-performance AI solutions designed to accelerate scientific discovery and empower technology innovation.
  • Inspur Information is a leading provider of data center infrastructure, cloud computing, and AI solutions.

Hero MotoSports Team Rally Bolsters Line-up With Another Top International Rider

Retrieved on: 
Thursday, February 3, 2022
Sports, Other Manufacturing, Automotive, Automotive Manufacturing, General Automotive, Motor Sports, Manufacturing, Licensing (Sports), Growth, Abu Dhabi Desert Challenge, Hero, Injury, Rider, Face, Motorcycle, Dream, Rookie, Hero MotoCorp, Abu Dhabi, MX1, Khawa, 2020 Dakar Rally, 2015 FIM Cross-Country Rallies World Championship, Multimedia, FIM, Dakar Rally, Ross Branch, Food delivery, Nightclub, Entertainment, Motocross

Close on the heels of its record-setting stage victory at the Dakar 2022 Hero MotoSports Team Rally, the motorsport team of the worlds largest manufacturer of motorcycles and scooters Hero MotoCorp has further strengthened its rider line-up by bringing onboard leading international rider, Ross Branch.

Key Points: 
  • Close on the heels of its record-setting stage victory at the Dakar 2022 Hero MotoSports Team Rally, the motorsport team of the worlds largest manufacturer of motorcycles and scooters Hero MotoCorp has further strengthened its rider line-up by bringing onboard leading international rider, Ross Branch.
  • With its consistent success in the global motorsports rally arena, the Hero MotoSports Team Rally has emerged as a much sought after team for leading riders.
  • Wolfgang Waffi Fischer, Team Manager, Hero MotoSports Team Rally said, We are excited to make a strong addition to our team, right after our historic stage win at the Dakar Rally.
  • Ross Branch, Rider, Hero MotoSports Team Rally said, I am thrilled and extremely honoured to be joining a team thats making the headlines for all the right reasons.

Synairgen Presents In Vitro Potency Data for Interferon Beta Against SARS-CoV-2 Variants and Lung Antiviral Biomarker Data for Inhaled SNG001 at the 8th ESWI Influenza Conference

Retrieved on: 
Tuesday, December 7, 2021
AIM, Synairgen, Company, COPD, LSE, MX1, University of Southampton, Gene expression, Conference, Drug discovery, European Scientific Cooperative on Phytotherapy, Food, Gamma, Patient, Inhalation, IFN, VOC, Alpha, Immortalised cell line, Chronic obstructive pulmonary disease, NIHR, Asthma, National Institute, Multimedia, COVID-19, University, Biomarker, Sputum, Interferon, National Institute for Health Research, FDA, Infection, OAS1, Poster, Cell, Severe acute respiratory syndrome coronavirus 2, US Foods, Vaccine, Medical device, Pharmaceutical industry

Synairgen is investigating the in vitro activity of SNG001 against the Delta and Omicron variants of SARS-CoV-2 and will make data available as soon as possible.

Key Points: 
  • Synairgen is investigating the in vitro activity of SNG001 against the Delta and Omicron variants of SARS-CoV-2 and will make data available as soon as possible.
  • "SNG001 is an investigational drug currently in Phase 3 trials, with the first data read out early in 2022, and contains the essential antiviral protein interferon beta, a protein that 'switches on' antiviral defences.
  • We presented data showing that SNG001 activates the lungs' antiviral defences for 24 hours after a dose has been delivered, supporting our once-a-day dosing schedule,"Dr Monk added.
  • The Company's primary focus is developing SNG001 (inhaled interferon beta) for the treatment of COVID-19 as potentially the first host-targeted, broad-spectrum antiviral treatment delivered directly into the lungs.

New Vice President of Global Sales appointed by iKOMG

Retrieved on: 
Thursday, September 9, 2021

PFAFFIKON, Switzerland, Sept. 9, 2021 /PRNewswire/ -- iKO Media Group , a global end-to-end service provider for broadcasters and content owners, is pleased to welcome Mr. Mark Berenshtein as Vice President of Global Sales North America & Special accounts.

Key Points: 
  • PFAFFIKON, Switzerland, Sept. 9, 2021 /PRNewswire/ -- iKO Media Group , a global end-to-end service provider for broadcasters and content owners, is pleased to welcome Mr. Mark Berenshtein as Vice President of Global Sales North America & Special accounts.
  • As VP of Global Sales, Berenshtein will lead development of strategic sales plans based on company goals to promote sales growth and client satisfaction for the organization.
  • Specific responsibilities include business and market development, strategic direction for promotion and advertising, sales growth, and client satisfaction.
  • His experience, track-record and goal-oriented mindset are key assets that will enhance iKOMG's offering and sales activities on a global scale.